Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioSight Ltd.

www.biosight-pharma.com

Latest From BioSight Ltd.

Venture Funding Deals, June 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced April through May 2016.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Synthesis Technologies, Production Processes
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • BioSight Ltd.
  • Senior Management
  • Ruth Ben Yakar, PhD, CEO
    Mark Gengrinovitch, CFO
    Stela Gengrinovitch, PhD, CSO
  • Contact Info
  • BioSight Ltd.
    Hanapach 34, Industrial Park
    P.O. Box 6372 Karmiel, 21653
    Israel
UsernamePublicRestriction

Register